Preoperative treatment with levosimendan in candidates for mechanical circulatory support

ASAIO Journal

Volumn 58, Issue 1, 2012, Pages 6-11

  Sponga, Sandro ^a   Ivanitskaia, Ekaterina ^a   Potapov, Evgenij ^a   Krabatsch, Thomas ^a   Hetzer, Roland ^a   Lehmkuhl, Hans ^a  

^a DEUTSCHES HERZZENTRUM BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIAC INDEXES; CENTRAL VENOUS PRESSURE; HEART FAILURE; HEMODYNAMIC PARAMETERS; LEFT VENTRICULAR ASSIST DEVICES; MECHANICAL CIRCULATORY SUPPORT; PULMONARY PRESSURES; RIGHT VENTRICULAR; RIGHT VENTRICULAR DYSFUNCTIONS;

BLOOD PRESSURE; HEMODYNAMICS; PATIENT MONITORING;

PATIENT TREATMENT;

BRAIN NATRIURETIC PEPTIDE; CARDIOTONIC AGENT; HYDRAZONE DERIVATIVE; PEPTIDE FRAGMENT; PRO BRAIN NATRIURETIC PEPTIDE (1 76); PRO-BRAIN NATRIURETIC PEPTIDE (1-76); PYRIDAZINE DERIVATIVE; SIMENDAN;

ADULT; AGED; ARTICLE; CENTRAL VENOUS PRESSURE; ECHOCARDIOGRAPHY; FEMALE; HEART ASSIST DEVICE; HEART RIGHT VENTRICLE FUNCTION; HEMODYNAMICS; HUMAN; INTENSIVE CARE; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; PRESSURE; STATISTICAL MODEL; TIME;

ADULT; AGED; CARDIOTONIC AGENTS; CENTRAL VENOUS PRESSURE; ECHOCARDIOGRAPHY; FEMALE; HEART-ASSIST DEVICES; HEMODYNAMICS; HUMANS; HYDRAZONES; INTENSIVE CARE; MALE; MIDDLE AGED; MODELS, STATISTICAL; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PRESSURE; PYRIDAZINES; TIME FACTORS; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 84855359650     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAT.0b013e318239f401     Document Type: Article

References (17)

1. Portner PM, Jansen PGM, Oyer PE, et al: Improved outcomes with an implantable left ventricular assist system: A multicenter study. Ann Thorac Surg 71: 205-209, 2001. (Pubitemid 32102661)
2. Vitali E, Colombo T, Bruschi G, et al Different clinical scenarios for circulatory mechanical support in acute and chronic heart failure. Am J Cardiol 96(suppl) 34L-41L 2005
3. J ohnson MR, Spokas D, Allen J, et al: The use of APACHE II scores to select candidates for left ventricular assist device placement. J Heart Lung Transplant 17: 1017-1023, 1998. (Pubitemid 28499033)
4. Frazier OH, Delgado RM: Mechanical circulatory support for advanced heart failure: Where does it stand in 2003? Circulation 108 3064-3068 2003 (Pubitemid 38031791)
5. Potapov EV, Stepanenko A, Dandel M, et al: Tricuspid incompetence and geometry of the right ventricle as predictors of right ventricular function after implantation of a left ventricular assist device. J Heart Lung Transplant. 27: 1275-1281, 2008.
6. Deng MC, Loebe M, El-Banayosi A: Mechanical circulatory support for advanced heart failure: Effect of patient selection on outcome. Circulation 103: 231-237, 2001. (Pubitemid 32095408)
7. O chiai Y, McCarthy PM, Smedira NG, et al: Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: Analysis of 245 patients. Circulation 106(suppl 1):I-198-202, 2002.
8. K ukucka M, Stepanenko A, Potapov E, et al: Right-to-left ventricular end-diastolic diameter ratio and prediction of right ventricular failure with continuous-flow left ventricular assist devices. J Heart Lung Transplant 30: 64-69, 2011.
9. Rose EA, Gelijns AC, Moskowitz AJ, et al: Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 345: 1435-1443, 2001.
10. Frazier OH, Myers TJ, Gregoric ID, et al: Initial clinical experience with the Jarvik 2000 implantable axial-flow left ventricular assist system. Circulation 105: 2855-2860, 2002. (Pubitemid 34666098)
11. O 'Connor CM, Gattis WA, Uretsky BF, et al: Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST). Am Heart J 138: 78-86, 1999. (Pubitemid 29331125)
12. Waldenberger F, Kim YI, Laycock S, et al: Effects of failure of the right side of the heart and increased pulmonary resistance on mechanical circulatory support with use of the miniaturized HIA-VAD displacement pump system. J Thorac Cardiovasc Surg 112: 484-493, 1996. (Pubitemid 26301860)
13. Mebazaa A, Erhardt L: Levosimendan: A new dual-action drug in the treatment of acute heart failure. Int J Clin Pract 57: 410-416, 2003. (Pubitemid 36805573)
14. Pagel PS, Harkin CP, Hettrick DA, Warltier DC: Levosimendan (OR-1259), a myofilament calcium sensitizer, enhances myocardial contractility but does not alter isovolumic relaxation in conscious and anesthetized dogs. Anesthesiology 81: 974-987, 1994. (Pubitemid 24332631)
15. C hristoph A, Prondzinsky R, Russ M, et al: Early and sustained haemodynamic improvement with levosimendan compared to intraaortic balloon counterpulsation (IABP) in cardiogenic shock complicating acute myocardial infarction. Acute Card Care 10: 49-57, 2008. (Pubitemid 351878180)
16. Nieminen MS, Bohm M, Cowie MR, et al: Executive summary of the guidelines on the diagnosis and treatment of acute heart failure. The Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 26: 384-416, 2005. (Pubitemid 40283098)
17. Daniels LD, Maisel AS. Natriuretic peptides. J Am Coll Cardiol 50 2357-2368 2007 (Pubitemid 50011582)